Stoke Therapeutics (STOK) Other financing activities (2018 - 2021)
Stoke Therapeutics (STOK) recorded quarterly Other financing activities of -$1000.0 in Q4 2021, down 200.0% quarter-over-quarter from $1000.0 in Q3 2021, and up 98.15% on a YoY basis from -$504.67 in Q4 2020.
Stoke Therapeutics (STOK) Other financing activities (2018 - 2021) Analysis & Trends
Stoke Therapeutics' Other financing activities history runs 4 years deep, the most recent figure standing at -$1000.0 for Q4 2021.
- In Q4 2021, Other financing activities rose 98.15% year-over-year to -$1000.0; the TTM figure through Dec 2021 stood at -$2.5 million (down 1178.68% YoY), while the FY2022 annual figure was $1000.0, up 150.0% from the prior year.
- Other financing activities was -$1000.0 for Q4 2021 at Stoke Therapeutics, down from $1000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $2.5 million in Q3 2019 to a low of -$2.5 million in Q4 2019.
- Historically, Other financing activities has averaged -$7125.0 across 4 years, with a median of -$1000.0 in 2018.
- The sharpest annual moves came in 2019 and 2020: Other financing activities soared 246500.0% in 2019, then soared 97.81% in 2020.
- A 4-year view of Other financing activities shows it stood at -$1000.0 in 2018, then plunged by 246400.0% to -$2.5 million in 2019, then jumped by 97.81% to -$54000.0 in 2020, then soared by 98.15% to -$1000.0 in 2021.
- The last three Other financing activities figures came in at -$1000.0 (Q4 2021), $1000.0 (Q3 2021), and -$54000.0 (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Stoke Therapeutics | 1.95 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Dec 31, 2020 | -54,000.00 |
| Dec 31, 2020 | -54,000.00 |
| Dec 31, 2019 | -2.47 Mn |
| Dec 31, 2019 | -2.47 Mn |
| Sep 30, 2019 | 2.46 Mn |
| Sep 30, 2019 | 2.46 Mn |
| Jun 30, 2019 | -142,000.00 |
| Jun 30, 2019 | -142,000.00 |
| Mar 31, 2019 | 141,000.00 |
| Mar 31, 2019 | 141,000.00 |
| Sep 30, 2018 | -1,000.00 |
| Sep 30, 2018 | -1,000.00 |